Podcast: Patel Cautions Against "Unintended Consequences" of mHealth Legislation
This article was originally published in The Gray Sheet
Executive Summary
Speaking to The Gray Sheet at the Food and Drug Law Institute's annual meeting, FDA's Bakul Patel cautioned against trying to cram too much into mobile health legislation and said the agency alongside FCC is still mulling how to proceed with standardizing wireless test beds.